Drug
pivekimab sunirine-pvzy
Marketed as DECNUPAZ.
Generic name
pivekimab sunirine-pvzy
Brand names
DECNUPAZ
First FDA approval
2026-05-27
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761460 | DECNUPAZ | 2026-05-27 | ABBVIE INC |
Manufacturers
ABBVIE INC
Frequently asked questions
When was pivekimab sunirine-pvzy FDA approved?
Earliest FDA approval on record: 2026-05-27.
What brand names are sold as pivekimab sunirine-pvzy?
DECNUPAZ.
Sources
Appeal a pivekimab sunirine-pvzy denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com